Human ILT-3 ELISA Kit is a single-wash 90-min SimpleStep ELISA® for the quantitative measurement of Human ILT-3 in Serum, Citrate plasma, EDTA Plasma, Heparin Plasma, Cell culture supernatant samples.
Colorimetric
Serum, Citrate plasma, EDTA Plasma, Heparin Plasma, Cell culture supernatant
Sandwich (quantitative)
Human
5.469 - 350 pg/mL
1h 30m
= 2 pg/mL
Application | Reactivity | Dilution info | Notes |
---|---|---|---|
Application sELISA | Reactivity Reacts | Dilution info - | Notes - |
Receptor for class I MHC antigens. Recognizes a broad spectrum of HLA-A, HLA-B, HLA-C and HLA-G alleles. Involved in the down-regulation of the immune response and the development of tolerance, e.g. towards transplants. Interferes with TNFRSF5-signaling and NF-kappa-B up-regulation. Inhibits receptor-mediated phosphorylation of cellular proteins and mobilization of intracellular calcium ions.
Leukocyte immunoglobulin-like receptor subfamily B member 4, CD85 antigen-like family member K, Immunoglobulin-like transcript 3, Leukocyte immunoglobulin-like receptor 5, Monocyte inhibitory receptor HM18, ILT-3, LIR-5, LILRB4, ILT3, LIR5
Human ILT-3 ELISA Kit is a single-wash 90-min SimpleStep ELISA® for the quantitative measurement of Human ILT-3 in Serum, Citrate plasma, EDTA Plasma, Heparin Plasma, Cell culture supernatant samples.
Leukocyte immunoglobulin-like receptor subfamily B member 4, CD85 antigen-like family member K, Immunoglobulin-like transcript 3, Leukocyte immunoglobulin-like receptor 5, Monocyte inhibitory receptor HM18, ILT-3, LIR-5, LILRB4, ILT3, LIR5
Colorimetric
Serum, Citrate plasma, EDTA Plasma, Heparin Plasma, Cell culture supernatant
Sandwich (quantitative)
Human
5.469 - 350 pg/mL
1h 30m
Pre-coated microplate (12 x 8 well strips)
= 2 pg/mL
105%
Sample | n | mean | SD | C.V. |
---|---|---|---|---|
Sample Serum | n 8 | mean - | SD - | C.V. 7.1 |
Sample | n | mean | SD | C.V. |
---|---|---|---|---|
Sample Serum | n 3 | mean - | SD - | C.V. 5.7 |
Sample type | Average % | Range |
---|---|---|
Sample type Serum | Average % = 105 | Range 101 - 111 % |
Sample type Citrate plasma | Average % = 92 | Range 82 - 99 % |
Sample type EDTA Plasma | Average % = 99 | Range 90 - 108 % |
Sample type Heparin Plasma | Average % = 103 | Range 100 - 107 % |
Sample type Cell culture supernatant | Average % = 101 | Range 98 - 104 % |
Blue Ice
+4°C
+4°C
+4°C
Human ILT-3 SimpleStep ELISA® kit is a single-wash 90 min sandwich ELISA designed for the quantitative measurement of ILT-3 protein in Serum, Cit Plasma, EDTA Plasma, Hep Plasma, Cell culture supernatant. Quantitate Human ILT-3 with 2 pg/ml sensitivity.
SimpleStep ELISA® technology employs capture antibodies conjugated to an affinity tag that is recognized by the monoclonal antibody used to coat our SimpleStep ELISA® plates. This approach to sandwich ELISA allows the formation of the antibody-analyte sandwich complex in a single step, significantly reducing assay time. See the SimpleStep ELISA® protocol summary in the image section for further details. Our SimpleStep ELISA® technology provides several benefits:
-Single-wash protocol reduces assay time to 90 minutes or less
-High sensitivity, specificity and reproducibility from superior antibodies
-Fully validated in biological samples
-96-wells plate breakable into 12 x 8 wells strips, available in 10-pack (10 x 96-well plates)
-Also available in a fully validated 384-well format.
This supplementary information is collated from multiple sources and compiled automatically.
ILT-3 also known as Immunoglobulin-like transcript 3 is a protein predominantly expressed on dendritic cells and monocytes. It is a type I transmembrane protein belonging to the leukocyte immunoglobulin-like receptor family. The ILT-3 protein has a molecular mass of approximately 60 kDa. In addition to its presence on dendritic cells and monocytes ILT-3 can be detected in low levels on some types of macrophages. It plays a regulatory role in the immune system which can influence how the body responds to pathogens and tissue damage.
ILT-3 acts as an inhibitory receptor that modulates immune responses. It is often linked with the control of T cell activation and the maintenance of immune tolerance. ILT-3 does not form part of a larger protein complex. Its inhibitory function helps in preventing overactivation of the immune system by modulating the signaling pathways necessary for immune response. This modulation occurs through ITIM (Immunoreceptor Tyrosine-based Inhibitory Motif) domains that recruit phosphatases helping in dephosphorylating key signaling proteins and aiding in downregulation of immune cell activities.
The ILT-3 protein is involved in important immune regulatory pathways contributing significantly to the immune checkpoint pathway. It interacts with other immunoglobulin-like receptors and is known to influence pathways involving PD-1 (Programmed cell death protein 1) and CTLA-4 (Cytotoxic T-lymphocyte-associated protein 4). By affecting these pathways ILT-3 serves as a checkpoint that ensures immune homeostasis prevents excess inflammation and influences the balance between immune activation and suppression within the body.
ILT-3 has been implicated in autoimmune diseases and transplant rejection. It helps in suppressing immune responses that can lead to conditions like rheumatoid arthritis and could negatively affect organ transplant outcomes by minimizing the chance of rejection. ILT-3's role in these conditions connects it to proteins such as HLA-G and PD-L1 which are also involved in immune modulation and contribute to disease pathogenesis. Understanding ILT-3’s role provides insights into potential therapeutic targets for these diseases.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Example of human ILT-3 standard curve in Sample Diluent NS. Example of human ILT-3 standard curve. Background-subtracted data values (mean +/- SD) are graphed.
Interpolated concentrations of human ILT-3 in in serum, plasma (citrate), plasma (EDTA), plasma (heparin), and THP-1 cell culture supernatant. Interpolated concentration of native ILT-3 was measured in duplicate at different sample concentrations. Undiluted samples are as follows: serum 50%, plasma (citrate) 50%, plasma (EDTA) 25%, plasma (heparin) 25%, and THP-1 cell culture supernatant 8%. The interpolated dilution factor corrected values (to neat sample) are plotted (mean +/- SD, n=2). Sample dilutions are made in Sample Diluent NS.
Example of human ILT-3 standard curve in Sample Diluent NS in 96-well vs. 384-well plate. Example of human ILT-3 standard curve in 96-well vs. 384-well plate. Background-subtracted data values (mean +/- SD) are graphed.
Interpolated concentrations of human ILT-3 in serum in 96-well vs. 384-well plates. Interpolated concentration of native ILT-3 was measured in duplicate at different sample concentrations in 96-well vs. 384-well plates. Undiluted samples are 50% serum. The interpolated dilution factor corrected values (to neat sample) are plotted (mean +/- SD, n=2). Sample dilutions are made in Sample Diluent NS.
Cross reactivity of related LILR family members. 50 ng/mL of recombinant human LILRA5 was tested for cross-reactivity. Percent reactivity was determined by interpolating the protein concentration from the human ILT-3 (LILRB4) standard curve and expressing the interpolated concentration as a percentage of the protein concentration tested. No cross reactivity was observed.
Interference testing of related LILR family members. 250 pg/mL of recombinant human LILRA5 was tested interference with 125 pg/ml of recombinant human ILT-3. Percent reactivity was determined by interpolating the protein concentration from the human ILT-3 (LILRB4) standard curve and expressing the interpolated concentration as a percentage of the protein concentration tested. No significant interference was observed.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com